BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11751392)

  • 1. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
    Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
    Kim SK; Cargioli TG; Machluf M; Yang W; Sun Y; Al-Hashem R; Kim SU; Black PM; Carroll RS
    Clin Cancer Res; 2005 Aug; 11(16):5965-70. PubMed ID: 16115940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
    Bello L; Lucini V; Costa F; Pluderi M; Giussani C; Acerbi F; Carrabba G; Pannacci M; Caronzolo D; Grosso S; Shinkaruk S; Colleoni F; Canron X; Tomei G; Deleris G; Bikfalvi A
    Clin Cancer Res; 2004 Jul; 10(13):4527-37. PubMed ID: 15240545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
    Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
    Bello L; Carrabba G; Giussani C; Lucini V; Cerutti F; Scaglione F; Landré J; Pluderi M; Tomei G; Villani R; Carroll RS; Black PM; Bikfalvi A
    Cancer Res; 2001 Oct; 61(20):7501-6. PubMed ID: 11606386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of glioma growth by systemic administration of human PEX.
    Pluderi M; Lucini V; Caronzolo D; Pannacci M; Costa F; Carrabba G; Giussani C; Grosso S; Colleoni F; Scaglione F; Villani R; Bikfalvi A; Bello L
    J Neurosurg Sci; 2003 Jun; 47(2):69-78. PubMed ID: 14618134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
    Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
    Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A; Wang L; López-Casillas F; Mendoza V; Yeh IT; Sun L
    Prostate; 2005 Apr; 63(1):81-90. PubMed ID: 15468171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.